{"id":483542,"date":"2021-04-28T16:04:45","date_gmt":"2021-04-28T20:04:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/"},"modified":"2021-04-28T16:04:45","modified_gmt":"2021-04-28T20:04:45","slug":"morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/","title":{"rendered":"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors"},"content":{"rendered":"

\nOtello Stampacchia steps down, Vikas Goyal to leave Morphic Board at the end of current term
\n<\/h2>\n
\n

WALTHAM, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic<\/a> (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of\u00a0Susannah Gray to its Board of Directors. Ms. Gray is an accomplished leader in healthcare finance and serves as a director on the boards of multiple healthcare companies. Ms. Gray was most recently the executive vice president of finance and strategy at Royalty Pharma.<\/p>\n

\u201cSusannah Gray brings a broad range of senior healthcare finance strategy experience to Morphic, with notable accomplishments in capital formation, strategy and corporate governance,\u201d stated Gustav Christensen, chairman of the Board of Directors of Morphic Therapeutic. \u201cI and the entire Morphic team welcome Susannah and we look forward to her contributions as Morphic continues to advance its portfolio of integrin-targeted oral therapeutics.\u201d<\/p>\n

\u201dMorphic Therapeutic has the rare combination of an innovative drug discovery platform coupled with the human and financial resources to create innovative therapies,\u201d commented Susannah Gray. \u201c I look forward to working with the Morphic team as they advance MORF-057 in clinical development and continue to generate oral integrin drug candidates based on the MInT Platform.\u201d<\/p>\n

Susannah Gray is a veteran leader in healthcare finance and strategy with three decades of experience in capital formation, operational management, healthcare asset monetization, investment research and strategy implementation. Ms. Gray is a member of the board of directors of corporate and non-profit institutions including Morphic Therapeutic, 4D Molecular Therapeutics, Maravai Life Sciences, Wesleyan University, Susan G. Komen Foundation and StreetSquash.<\/p>\n

Susannah Gray was executive vice president and chief financial officer at Royalty Pharma from 2005-2019. Prior to Royalty Pharma, she served as managing director of fixed income research at CIBC World Markets and held positions of increasing leadership at Chase Securities and Merrill Lynch. Susannah Gray holds a BA from Wesleyan University and an MBA from Columbia University Business School.<\/p>\n

Simultaneously, Otello Stampacchia, Ph.D., has stepped down from the Morphic Board of Directors. Praveen Tipirneni, M.D., president and chief executive officer of Morphic Therapeutic, commented: \u201cOn behalf of Gustav and the Morphic Board, I want to thank Otello for his counsel and many contributions to Morphic\u2019s growth as it has matured from a preclinical organization based on an ambitious technology to the promising clinical company that we have become.\u201d<\/p>\n

\u201cIt has been a pleasure to be a part of the Morphic team and I commend the Company for the tremendous progress it has made in advancing several novel oral integrin therapeutic candidates in areas of significant unmet medical need,\u201d said Otello Stampacchia.<\/p>\n

Further, Vikas Goyal has determined that he will not stand for re-election to the Morphic Board of Directors when his current term expires. \u201cIt has been my privilege and honor to serve as a director of Morphic since the Series A financing of the Company,\u201d commented Vikas Goyal. \u201cMorphic\u2019s notable advances in this technically challenging area of drug development are a testament to the team and the technology, and I wish them continued success.\u201d<\/p>\n

\u201cWe thank Vikas deeply for his early recognition of the potential to create oral integrin medicines through the MInT platform and his steadfast support of the Morphic team. I also congratulate him on his recent successes at Pandion and look forward to collaborating again in the future,\u201d stated Tipirneni.<\/p>\n

\n About Morphic Therapeutic<\/strong>
\n
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schr\u00f6dinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT platform which leverages the Company\u2019s unique understanding of integrin structure and biology. For more information, visit\u00a0www.morphictx.com<\/a>.<\/p>\n

\n Cautionary Note Regarding Forward-Looking Statements<\/strong>
\n
This press release contains \u201cforward-looking statements\u201d within the meaning of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, and of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: the MInT Platform\u2019s ability to discover drug candidates, Morphic\u2019s plans to develop and commercialize oral small-molecule integrin therapeutics, any expectations about safety, efficacy, timing and ability to commence or complete clinical studies and to obtain regulatory approvals for its candidates in development, and the ability of its candidates in development to treat serious chronic diseases.<\/p>\n

Statements including words such as \u201cbelieve,\u201d \u201cplan,\u201d \u201ccontinue,\u201d \u201cexpect,\u201d \u201cwill,\u201d \u201cdevelop,\u201d \u201csignal,\u201d \u201cpotential,\u201d or \u201congoing\u201d and statements in the future tense are forward-looking statements. These forward-looking statements involve risks and uncertainties, as well as assumptions, which, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements.<\/p>\n

Forward-looking statements are subject to risks and uncertainties that may cause Morphic\u2019s actual activities or results to differ significantly from those expressed in any forward-looking statement, including risks and uncertainties in this press release and other risks set forth in our filings with the\u00a0Securities and Exchange Commission, including Morphic\u2019s or a partner\u2019s ability to develop, obtain regulatory approval for or commercialize any product candidate, Morphic\u2019s ability to protect intellectual property, the potential impact of the COVID-19 pandemic and the sufficiency of our cash, cash equivalents and investments to fund our operations. We urge you to consider those factors, and the other risks and uncertainties described in our most recent annual report on Form 10-K as filed with the Securities and Exchange Commission (SEC), any subsequent quarterly reports on Form 10-Q as well as in other documents that may be subsequently filed by Morphic from time to time with the SEC, in evaluating our forward-looking statements. These forward-looking statements speak only as of the date hereof and\u00a0Morphic\u00a0specifically disclaims any obligation to update these forward-looking statements or reasons why actual results might differ, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

\n Contacts<\/strong>
\n
Morphic Therapeutic
Chris Erdman
chris.erdman@morphictx.com<\/a>
617.686.1718<\/p>\n

Media Contact
Tom Donovan, Ten Bridge Communications
tom@tenbridgecommunications.com<\/a>
857.559.3397<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Otello Stampacchia steps down, Vikas Goyal to leave Morphic Board at the end of current term WALTHAM, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of\u00a0Susannah Gray to its Board of Directors. Ms. Gray is an accomplished leader in healthcare finance and serves as a director on the boards of multiple healthcare companies. Ms. Gray was most recently the executive vice president of finance and strategy at Royalty Pharma. \u201cSusannah Gray brings a broad range of senior healthcare finance strategy experience to Morphic, with notable accomplishments in capital formation, strategy and corporate governance,\u201d stated Gustav Christensen, chairman of the Board of Directors of Morphic Therapeutic. \u201cI … <\/p>\n

Continue reading “Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-483542","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMorphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Otello Stampacchia steps down, Vikas Goyal to leave Morphic Board at the end of current term WALTHAM, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of\u00a0Susannah Gray to its Board of Directors. Ms. Gray is an accomplished leader in healthcare finance and serves as a director on the boards of multiple healthcare companies. Ms. Gray was most recently the executive vice president of finance and strategy at Royalty Pharma. \u201cSusannah Gray brings a broad range of senior healthcare finance strategy experience to Morphic, with notable accomplishments in capital formation, strategy and corporate governance,\u201d stated Gustav Christensen, chairman of the Board of Directors of Morphic Therapeutic. \u201cI … Continue reading "Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-28T20:04:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors\",\"datePublished\":\"2021-04-28T20:04:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/\"},\"wordCount\":1031,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/\",\"name\":\"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=\",\"datePublished\":\"2021-04-28T20:04:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/","og_locale":"en_US","og_type":"article","og_title":"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors - Market Newsdesk","og_description":"Otello Stampacchia steps down, Vikas Goyal to leave Morphic Board at the end of current term WALTHAM, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of\u00a0Susannah Gray to its Board of Directors. Ms. Gray is an accomplished leader in healthcare finance and serves as a director on the boards of multiple healthcare companies. Ms. Gray was most recently the executive vice president of finance and strategy at Royalty Pharma. \u201cSusannah Gray brings a broad range of senior healthcare finance strategy experience to Morphic, with notable accomplishments in capital formation, strategy and corporate governance,\u201d stated Gustav Christensen, chairman of the Board of Directors of Morphic Therapeutic. \u201cI … Continue reading \"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-28T20:04:45+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors","datePublished":"2021-04-28T20:04:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/"},"wordCount":1031,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/","name":"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=","datePublished":"2021-04-28T20:04:45+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIyNTc3MyM0MTQ0ODU4IzIxODc0MzU="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/morphic-therapeutic-announces-appointment-of-susannah-gray-as-member-of-its-board-of-directors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=483542"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/483542\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=483542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=483542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=483542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}